English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background Combined vaccine of diphtheria, whole-cell pertussis, tetanus, and hepatitis B (DPwT/HB) will reduce the number of injections to children and simplify the delivery logistics. The adverse events following immunization (AEFI) of this vaccine have to be concerned since the events may increase or decrease. Objectives To evaluate AEFI of DPwT/HB vaccine in healthy infants. Methods A descriptive prospective study of AEFI of three doses of DPwT/HB vaccine was performed on 74 healthy infants aged two to six months at the Department of Child Health, Cipto Mangunkusumo Hospital, from July 2000 to March 2001. Results Out of 74 infants, 68 received two doses and 67 completed the study with a total of 209 doses. Of 209 doses, adverse events were reported following 126 doses (60.3%), consisted of systemic (60.3%) and local reactions (9.5%). The three most frequent AEFI iwere mild fever (44.5%), high fever (15.7%), irritability (31.5%). Most AEFI were coincidental (51.1%), occurred after more than 72 hours (31.4%) and lasted less than 24 hours (17.7%). Systemic reactions were mostly found in 4-month-old infants (33.3%), while local reactions in 2-, 3-, and 5-month-old infants (25%), respectively. Conclusion Most AEFI were coincidental and resolved without any complication [Paediatr Indones 2004;44:209-214].

Adverse events following immunization of combined diphtheria, whole-cell pertussis, tetanus, and hepatitis B (DPwT/HB) vaccine